Thermo Fisher Scientific Quarterly Income Statement
NYSE: TMOIndustrialsIndustrial Machinery/ComponentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Thermo Fisher Scientific revenue and earnings
In the quarter ended Jun 27, 2026, Thermo Fisher Scientific generated $11.99 billion in revenue, up 10.5% from the same quarter a year earlier. Net income was $1.74 billion (+7.4% year over year), for a net margin of 14.5% versus a median of 14.9% in the prior 5 quarters. Operating margin was 17.4%.
Diluted earnings per share came in at $4.68, up from $4.28.
Summary generated from market data by MetaCap's automated system. Methodology
Thermo Fisher Scientific income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-27 | Q1 20262026-03-28 | Q4 20252025-12-31 | Q3 20252025-09-27 | Q2 20252025-06-28 | Q1 20252025-03-29 | Q4 20242024-12-31 | Q3 20242024-09-28 | Q2 20242024-06-29 | Q1 20242024-03-30 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11.99B | 11.01B | 12.21B | 11.12B | 10.86B | 10.36B | 11.39B | 10.60B | 10.54B | 10.35B | 10.89B | 10.57B |
| Revenue growth (YoY) | +10.49% | +6.18% | +7.20% | +4.94% | +2.98% | +0.18% | +4.68% | +0.23% | -1.37% | -3.41% | -4.93% | -0.96% |
| Research & Development | 364.00M | 336.00M | 356.00M | 346.00M | 352.00M | 342.00M | 374.00M | 346.00M | 339.00M | 331.00M | 327.00M | 319.00M |
| Selling, General & Admin | 2.33B | 2.18B | 2.35B | 2.16B | 2.14B | 2.08B | 2.20B | 2.10B | 2.11B | 2.18B | 2.13B | 2.05B |
| Operating Income | 2.09B | 1.86B | 2.25B | 1.94B | 1.83B | 1.72B | 2.02B | 1.84B | 1.82B | 1.66B | 1.85B | 1.86B |
| Interest Expense | 401.00M | 354.00M | 365.00M | 347.00M | 404.00M | 303.00M | 317.00M | 356.00M | 354.00M | 363.00M | 390.00M | 359.00M |
| Other Income (Expense) | 31.00M | -9.00M | 6.00M | -2.00M | -19.00M | 3.00M | 14.00M | -16.00M | 5.00M | 10.00M | -33.00M | 14.00M |
| Pretax Income | 1.92B | 1.73B | 2.15B | 1.83B | 1.71B | 1.62B | 1.94B | 1.74B | 1.76B | 1.59B | 1.74B | 1.76B |
| Income Tax | 167.00M | 70.00M | 153.00M | 207.00M | 92.00M | 95.00M | 150.00M | 99.00M | 128.00M | 281.00M | 133.00M | 53.00M |
| Net Income | 1.74B | 1.65B | 1.96B | 1.62B | 1.62B | 1.51B | 1.83B | 1.63B | 1.55B | 1.33B | 1.61B | 1.70B |
| Net Income growth (YoY) | +7.36% | +9.56% | +7.32% | -0.86% | +4.46% | +13.22% | +13.95% | -3.83% | +13.66% | +3.02% | +2.03% | +13.15% |
| EPS (Basic) | 4.68 | 4.44 | 5.22 | 4.28 | 4.28 | 3.99 | 4.80 | 4.26 | 4.05 | 3.47 | 4.21 | 4.44 |
| EPS (Diluted) | 4.68 | 4.43 | 5.21 | 4.27 | 4.28 | 3.98 | 4.78 | 4.25 | 4.04 | 3.46 | 4.20 | 4.42 |
| Shares Outstanding (Basic) | 371.00M | 372.00M | — | 378.00M | 378.00M | 378.00M | — | 382.00M | 382.00M | 382.00M | — | 386.00M |
| Shares Outstanding (Diluted) | 371.00M | 373.00M | — | 378.00M | 378.00M | 379.00M | — | 384.00M | 383.00M | 384.00M | — | 388.00M |
| EBITDA | 2.42B | 2.17B | 2.55B | 2.17B | 2.09B | 1.99B | 2.32B | 2.13B | 2.10B | 1.95B | 2.13B | 2.13B |
| Operating Margin | 17.40% | 16.93% | 18.46% | 17.45% | 16.90% | 16.56% | 17.69% | 17.34% | 17.27% | 16.08% | 17.03% | 17.63% |
| Net Margin | 14.47% | 15.00% | 16.08% | 14.53% | 14.90% | 14.54% | 16.06% | 15.38% | 14.69% | 12.87% | 14.75% | 16.03% |
This table shows 12 quarterly periods of Thermo Fisher Scientific's income statement, from Q2 2026 back to Q3 2023, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow TMO's reporting calendar. What is a income statement?